Evidence map›Paper›PMID 41364132›Full record

ArticleNeurogenetics2025

LAMB1-associated leukoencephalopathy: a continuum from a prenatal, recessive syndrome to a dominant, adult-onset disorder.

José Zamora, Víctor Faundes

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Neurogenetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. LAMB1-related adult-onset leukoencephalopathy presenting with cognitive decline: diagnostic workup and review of the literature.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

José ZamoraUnidad de Neurología Infantil, Servicio de Pediatría, Hospital Dr. Gustavo Fricke, Viña del Mar, Chile. zamoracaro2003@yahoo.es.
Víctor FaundesLaboratorio de Genética y Enfermedades Metabólicas, Instituto de Nutrición y Tecnología de los Alimentos (INTA), Universidad de Chile, Santiago, Chile.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 1 year 11 months-old female patient displayed focal seizures symptoms with good response to oxcarbazepine. Her brain magnetic resonance imaging (MRI) showed white-matter, bilateral and symmetrical hyperintense foci in periventricular parietal and frontal regions with U-fiber sparing. A gene panel requested for the study of leukodystrophies and subsequent segregation reported compound heterozygous variants in LAMB1 gene: c.3659_3660delTG (p.Val1220Glyfs*31), maternally inherited, and c.2942 A > T (p.Asn981Ile), paternally inherited. Published cases with biallelic, loss-of-function LAMB1 variants displayed a broad phenotype that depends on the deleteriousness of the variants, ranging from mildly affected individuals to severely affected ones with multiple other anomalies. Also, monoallelic, presumably toxic gain-of-function LAMB1 variants can also cause leukoencephalopathy but whose onset of manifestations is in adulthood. The cases affected by the dominant condition also exhibit a broad range of manifestations and brain imaging anomalies, some of them overlap to those seen in the recessive LAMB1-related leukoencephalopathy. This work unveils the relevance of performing a comprehensive literature review for a better comprehension of overlapping conditions caused by variants in the same gene.

Indexed as

LamininLeukoencephalopathiesAge of OnsetBrainFemaleGenes, RecessiveHumansInfantMagnetic Resonance ImagingMutationPhenotypeLamininGain of functionLamininLeukoencephalopathyLoss of function

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.